KaloBios CEO: post-Shkreli 'restart' and 'responsible' drug pricing
As the company tries to move out from under Shkreli's cloud, KaloBios has announced a new product pricing model that promises transparency, affordably, and reasonable return.
Archives for May 2, 2016
Codexis completes transfer of protein engineering tech to US GSK site
Codexis has completed the transfer of its protein engineering platform to a GSK earning it a $7.5m milestone payment.
update
EDQM: Harmonized generic drug reviews would help regulators, pharmas and patients
Increased use of generics has put pressure on drug reviewers according to the EDQM which has called for more cross border collaboration and harmonization of regulations.
Quintiles, IMS Health merge
Quintiles and IMS Health have merged to form Quintiles IMS Holdings, effectively creating one of the world’s largest healthcare information portfolios.
Samsung on Samsung: Bioepis selects Biologics as a biosimilars CMO
Samsung Biologics has been contracted by its joint venture entity Samsung Bioepis to manufacturer biosimilars from its facility in Korea.
Placing quality and innovation at the heart of drug development
Next week, sponsors and CROs will gather in Princeton, New Jersey to discuss how integrating quality, innovation and collaboration can transform the clinical trial process, bringing medicines to patients in a more expedited manner.